Uncharted Territory: Investigating Long-Term Quality of Survival After A Prostate Cancer Diagnosis

Authors:
Alicia K. Morgans Dana-Farber Cancer Institute, Boston, MA

Search for other papers by Alicia K. Morgans in
Current site
Google Scholar
PubMed
Close
 MD, MPH
and
Charles J. Ryan Memorial Sloan Kettering Cancer Center, New York, NY

Search for other papers by Charles J. Ryan in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Disclosures: Dr. Morgans has disclosed serving as a consultant for AstraZeneca, Astellas, Bayer, Curium, Exelixis, Janssen, Lantheus, Macrogenics, Merck, Novartis, Pfizer, Telix, Tolmar, Sanofi, and Sumitomo Pharma America, Inc.; and receiving grant/research support from Astellas, Bayer, Janssen, Pfizer, Sumitomo Pharma America, Inc. Dr. Ryan has disclosed serving as a consultant for Pfizer; and serving as a scientific advisor for Oric and Bayer.

Correspondence: Alicia K. Morgans, MD, MPH, Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana 9-930, Boston, MA 02215. Email: aliciak_morgans@dfci.harvard.edu
  • Collapse
  • Expand
  • 1.

    Meissner VH, Imhof K, Jahnen M, et al. Frailty in long-term prostate cancer survivors and its association with quality of life and emotional health. J Natl Compr Canc Netw 2025;23:e247066.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    James ND, Tannock I, N’Dow J, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 2024;403:1683722.

  • 3.

    Boyle HJ, Alibhai S, Decoster L, et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer 2019;116:116136.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Dale W, Klepin HD, Williams GR, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol 2023;41:42934312.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Kenfield SA, Batista JL, Jahn JL, et al. Development and application of a lifestyle score for prevention of lethal prostate cancer. J Natl Cancer Inst 2016;108:djv329.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003;21:16531659.

  • 7.

    Morgans AK, Lehmann R, Heidenreich A, et al. Identifying patient profiles and mapping the patient journey across three countries in a large-scale, fully digital survey of patients with prostate cancer. J Clin Oncol 2022;40(Suppl 6):Abstract 16.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 8042 8042 8042
PDF Downloads 717 717 717
EPUB Downloads 0 0 0